RNA-Seq data analysis of CRISPR/Cas9 knockout of the PRLR in HR+ breast cancer cells revealed the oncogenic CCN2 gene as the most upregulated target gene, highlighting an antagonistic relationship between PRLR and CCN2 gene expression. The gene discussed is CCN2; the disease is breast carcinoma.